- Previous Close
13.66 - Open
13.86 - Bid --
- Ask --
- Day's Range
13.39 - 13.86 - 52 Week Range
7.58 - 21.44 - Volume
6,991 - Avg. Volume
34,067 - Market Cap (intraday)
180.102M - Beta (5Y Monthly) 3.29
- PE Ratio (TTM)
-- - EPS (TTM)
-0.79 - Earnings Date Oct 17, 2024 - Oct 21, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
38.00
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
greenwichlifesciences.comRecent News: GLSI
View More
Performance Overview: GLSI
Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GLSI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GLSI
View MoreValuation Measures
Market Cap
179.56M
Enterprise Value
172.33M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
30.56
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-72.45%
Return on Equity (ttm)
-123.67%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-10.22M
Diluted EPS (ttm)
-0.79
Balance Sheet and Cash Flow
Total Cash (mrq)
7.22M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3.15M
Research Analysis: GLSI
View MoreCompany Insights: GLSI
GLSI does not have Company Insights
Research Reports: GLSI
View MoreDaily – Vickers Top Insider Picks for 10/04/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 10/03/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 10/02/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 10/01/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.